Immunic Inc.
- Biotech or pharma, therapeutic R&D
Immunic is a phase 3 stage biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
June 16-19, 2025
Boston Convention & Exhibition Center
Immunic is a phase 3 stage biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.